Search results for: Amanda Cole
Filter search results
OHE at ISPOR Europe 1: Impact of NICE on Innovation and Value
22 October 2014
…10 Nov, 15:30–19:30) NICE’s effect on innovation and access to medical technologies 2. Are the UK Systems of Innovation and Evaluation of Medical Devices Compatible? Amanda Chapman (OHE, presenting), Celia…
OHE at ISPOR Europe: Posters
13 November 2014
…Sussex, Dyfrig Hughes (Bangor University) and Nancy Devlin Ispor are uk_systems_innovation_compatible_ac from Office of Health Economics Amanda Chapman, C. A. Taylor (University of Birmingham) and A. J. Girling (University…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
…improved access to data within the appropriate arrangements for governance. Access the full report here. For more information contact Amanda Chapman or Sarah Karlsberg Schaffer at OHE. …
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…2022. https://www.gov.uk/government/publications/the-green-book-appraisal-and-evaluation-in-central-governent/the-green-book-2020 Danish Ministry of Finance. Dokumentationsnotat – den samfundsøkonomiske diskonteringsrente (machine translation). Published online January 7, 2021. https://fm.dk/media/18371/dokumentationsnotat-for-den-samfundsoekonomiske-diskonteringsrente_7-januar-2021.pdf Besley, S., Henderson, N., Towse, A. & Cole, A. (2022) Health…
How Restrictive are NICE ‘Optimised’ Decisions?
27 April 2023
…of recommendations would help paint a more accurate picture of recommended levels of patient access associated with NICE decision outcomes. Citations Bulut, M., O’Neill, P. and Cole, A. (2020) NICE…
OHE Lunchtime Seminar: How Cost-Effective are New Cancer Drugs in the U.S.?
18 September 2017, 11:00pm
…University of Pennsylvania. Prof. Lichtenberg previously taught at Harvard University, the University of Pennsylvania, and Ecole Polytechnique. He has served as an expert for the Federal Trade Commission, the U.S….
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
…Cole received no funding for this article, but has undertaken related work on the topic of the IRA with funding from PhRMA. References CMS, 2023. Medicare Drug Price Negotiation Program:…
Drug shortages are on the rise – but what is their impact?
16 September 2024
…Cole, A. and Cookson, G., 2024. The Dynamics of Drug Shortages. [online] OHE – Leading intellectual authority on global health economics. Available at: https://www.ohe.org/publications/the-dynamic-of-drug-shortages [Accessed 10 May 2024]. Nonzee, N.J. and Luu,…
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
…and Culyer, A.J., 2010. Discounting and decision making in the economic evaluation of health care technologies’. Health Economics, 20, pp.2–15. 10.1002/hec.1612. Cole, M.A., 2003. Development, trade, and the environment: how…